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Abstract
Affective symptoms such as anxiety and depression are frequently observed in patients with epilepsy. The mechanisms of
comorbidity of epilepsy and affective disorders, however, remain unclear. Diverse models are traditionally used in epilepsy
research, including the status epilepticus (SE) model in rats, which are aimed at generating chronic epileptic animals;
however, the implications of different SE models and rat strains in emotional behaviors has not been reported. To address
this issue, we examined the emotional sequelae of two SE models of temporal lobe epilepsy (TLE) – the lithium-pilocarpine
(LIP) model and the kainic acid (KA) model – in two different rat strains (Wistar and Sprague-Dawley), which differ
significantly in the pattern and extent of TLE-associated brain lesions. We found differences between LIP- and KA-treated
animals in tests for depression-like and anxiety-like behaviors, as well as differences in plasma corticosterone levels. Whereas
only LIP-treated rats displayed increased motivation to consume saccharin, both SE models led to reduced motivation for
social contact, with LIP-treated animals being particularly affected. Evaluation of behavior in the open field test indicated
very low levels of anxiety in LIP-treated rats and a mild decrease in KA-treated rats compared to controls. After exposure to a
battery of behavioral tests, plasma corticosterone levels were increased only in LIP-treated animals. This hyperactivity in the
hypothalamus-pituitary-adrenocortical (HPA) axis was highly correlated with performance in the open field test and the
social interaction test, suggesting that comorbidity of epilepsy and emotional behaviors might also be related to other
factors such as HPA axis function. Our results indicate that altered emotional behaviors are not inherent to the epileptic
condition in experimental TLE; instead, they likely reflect alterations in anxiety levels related to model-dependent
dysregulation of the HPA axis.
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Introduction
Affective disorders (e.g., anxiety and depression) frequently co-
occur with epilepsy, producing a negative impact on the quality of
life of those affected [1,2]. Although depression and anxiety are
common co-morbidities of temporal lobe epilepsy (TLE), the
underlying mechanisms are poorly understood. It has been
suggested that the affective symptoms associated with epilepsy
are secondary to seizures [3], and it has been hypothesized that
shared biological factors might both cause seizures and lead to
affective disturbances [4].
Several studies have investigated different aspects of affective
disorders, including physiological, behavioral and endocrine
factors, in experimental models of epilepsy. Using lithium-
pilocarpine and kainate status epilepticus (SE) models, previous
studies reported conflicting results for the performance of epileptic
rats in the elevated plus maze, an unconditioned, spontaneous test
of anxiety [5–7]. In the social recognition test, in which rats are
typically exposed to a juvenile conspecific rat, SE models have
been shown alterations of socialization, with animals often
displaying increased passivity toward the unfamiliar peer [8].
Moreover, it has been reported that animals subjected to lithium-
chloride and pilocarpine develop impairments congruent with
depression-like symptoms such as anhedonia, which is defined as
the inability to experience pleasure from activities formerly found
enjoyable (e.g., in rodents, an innate preference toward sweets) [9],
along with deregulation of the hypothalamus-pituitary-adrenocor-
tical (HPA) axis [10].
In a recent study [11], we compared two SE models of
chronic epilepsy in rats, using systemic administration of
lithium-pilocarpine (LIP) or kainic acid (KA). These models
are known to reproduce most of the clinical and neuropatho-
logical features of human TLE (e.g., hippocampal cell loss,
mossy fiber sprouting and dentate gyrus cell dispersion) [12–13].
In some of these SE models, neuronal loss is not restricted to
the sclerotic hippocampus and occurs in the parahippocampal
cortical regions, the thalamus, endopiriform cortex and the
amygdala [11,12,14–17]. At least some of these areas, such as
the amygdala, are involved not only in cognitive deficits but
also in emotional dysfunctions [18,19]. The validation of animal
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disorders is an important instrument for understanding the
underlying mechanisms and for developing new therapies.
However, none of the previous studies has compared the
impact of different experimental models and rat strain on
endocrine factors and emotional behavior.
Here, we examined the emotional behaviors of chronic epileptic
rats using two different SE models of TLE (LIP and KA) in two
different rat strains (Wistar and Sprague-Dawley). Our previous
results indicated that although both models reproduce most
features of human TLE, they also differ significantly regarding the
pattern and extent of extra-hippocampal brain lesions [11]. Thus,
using these models simultaneously allows us to examine the effect
of different lesion patterns on emotional performance. Because
depression and anxiety in epilepsy have been regarded as
multifactorial disorders [20,21], their investigation should include
the identification of different contributing factors, such as the
psychological and the endocrine components. Thus, we used
different behavioral tasks, including tests for social interaction and
anhedonia, to assess depressive symptoms and the open field to
evaluate anxiety-like behaviors, and we assessed the activity of the
HPA axis by assessing the plasmatic corticosterone level, the major
glucocorticoid in rodents.
Methods
All procedures met the European guidelines for animal
experiments (86/609/EEC). Protocols were approved by the
Ethics Committee at the Instituto Cajal for the application grants
BFU2009-07989 and MemStick (201600).
Animals
Adult male Wistar and Sprague-Dawley rats weighing 180–
200 g were obtained from Harlan Laboratories and our in-house
animal facilities at the Cajal Institute in Madrid. Rats were housed
in groups of four animals per cage under controlled conditions
(2262uC and 12:12 light–dark cycle, lights on at 7 a.m.). The
animals were given free access to food and water. All procedures
met the European guidelines for animal experiments (86/609/
EEC).
Lithium-pilocarpine (LIP) Treatment
Rats from both strains were injected with pilocarpine hydro-
chloride i.p. 12–24 hrs after receiving an injection of lithium
chloride (127 mg/kg, i.p.) [13]. Between one and four doses of
10 mg/kg pilocarpine were injected every 30 min until SE was
reached. SE was defined as a condition of continuous seizures
lasting longer than 30 min. Diazepam (4 mg/kg, i.p.) was injected
1 hour after SE and repeated during the following 24 hours if
convulsive behaviors persisted. Animals were injected with 2.5 ml
of 5% dextrose i.p. several times a day, and their diet was
supplemented with fruit and powdered milk during the following
2–3 days.
Kainic Acid (KA) Treatment
Independent sets of rats of both strains were injected with kainic
acid (5 mg/kg, i.p.) at hourly intervals until they reached SE [22].
Two to four doses of 5 mg/kg kainic acid were required to reach
SE in different animals. Similar to the LIP-treated rats, the
convulsive SE was interrupted by diazepam (4 mg/kg, i.p.) one
hour after observing the first symptoms. Animals that did not
exhibit SE after four doses of 5 mg/kg kainic acid were considered
resistant and excluded from the study.
Control Group
The control group was composed of rats treated with vehicle
(saline) instead of pilocarpine or kainic acid in the two different
strains, i.e., control Wistar (Control W, n=13) and control
Sprague-Dawley (Control SD, n=9). Control animals received
similar treatment as the experimental group: lithium and
diazepam for the lithium-pilocarpine model and diazepam for
the kainate model.
Experimental Design
Epileptic rats were assigned to one of four groups according to
treatment and strain: KA-Wistar (n=8), KA-Sprague-Dawley
(n=7), LIP-Wistar (n=9) and LIP-Sprague-Dawley (n=9). Tests
typically started approximately 8 weeks post-SE, when animals
exhibited spontaneous seizures. Control animals were grouped as
outlined above. Rats were handled for 4 days before being
subjected to the saccharin reward test to evaluate anhedonia. One
week later, animals were evaluated in the open-field test to
examine exploration and anxiety-like behaviors and assessed in the
social interaction test to detect alterations in social motivation.
Possible confounding effects of seizure and other epileptiform
activities were carefully controlled using the following measures.
First, behavioral tests were suspended for at least two hours for rats
that exhibited spontaneous seizures. Second, we considered
possible pre-seizure effects by excluding animals that experienced
at least one seizure within the hour following test completion. All
behavioral tasks were performed between 9:00 and 14:00 hours,
except for the anhedonia test, which was performed during the
dark phase. We measured the concentration of corticosterone in
the plasma twice. The first sample (‘‘pre-behavioral corticoste-
rone’’) was obtained before the behavioral testing but after the
animal was in the chronic phase of TLE. The second sample
(‘‘post-behavioral corticosterone’’) was obtained after all behav-
ioral tasks had been performed.
Anhedonia Test
Theexaminationofanhedoniainrodentstakesadvantageoftheir
innate preference for sweets and can be carried out using the
saccharin consumption test [9]. In this test, when given access to
both tap water and a saccharin solution, a healthy subject will
strongly prefer the latter, while animals with experimental
depression consume equal amounts of water and saccharin. This
loss of sweet taste preference has been validated as an indicator of
anhedonia [9]. The experimental and control groups were tested at
thesametime,andallgroupsreceivedtwodaysofhabituationtothe
new bottle configuration (two bottles filled with tap water placed in
the home cage for 12 hours) prior to the test. A two-bottle choice
procedure was used to determine baseline saccharin intake. During
each test, non-food-deprived rats were presented with two bottles
(tapwaterand1%saccharinsolution)intheirhomecageforaperiod
of12 hduringthedarkcycle.Intakewasdefinedasthedifferencein
bottle weight determined before and after the test. The location of
the bottle of saccharin solution relative to the other bottle was
counterbalanced across the rats. Saccharin consumption was
calculated as the amount consumed in grams per 100 g body
weight, and saccharin preference was calculated as saccharin
intake/total fluid intake (water + saccharin).
Open-field Test
Anxiety-like behavior and locomotor activity were assessed in
the open-field test, which was conducted within a rectangular
arena (50683656 cm). The lighting of the arena was adjusted to
be 6–8 l6 in the center of the maze. For analysis, the floor was
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middle of the arena (30663 cm) and an exterior area composed of
the remaining area along the side walls. At the start of the test,
animals were placed in the center of the arena, and their behavior
was monitored for 10 min using a video camera mounted on the
ceiling above the center of the arena. A computerized tracking
system (Ethovision 1.50, Noldus IT, Wageningen, Netherlands)
recorded the amount of time spent in each zone and the total
locomotion. A measure of innate anxiety level to open field
exploration was assessed by estimating the percentage of time
spent in the central zone. After each trial, the field was cleaned
with acetic acid (0.1%).
Social Interaction Test
The social interaction test was carried out in a rectangular,
three-chambered box (center compartment: 20650650 cm; left
and right compartments: 40650650 cm) fabricated from gray,
opaque polycarbonate. The dividing walls had retractable
doorways that allowed access to each transparent Plexiglas
cylinder. For habituation to the cylinder, each juvenile rat (5–6
weeks old) used in the social interaction test (n=4) was placed
alone in the cylinder for 5 min on 3 consecutive days preceding
the social test. The day after the last habituation session, each rat
was placed in the center compartment and allowed to explore for
10 min. Next, an unfamiliar juvenile rat was enclosed in one of the
cylinders, which was placed in one of the two sides of the social test
box during the 5 min session. A plastic bottle was placed in the
other cylinder on the other side of the box. Previous pilot studies
confirmed that the animals do not show a preference for this
object. The locations of the juvenile rat and the object in either the
left or right sides of the chamber were counterbalanced between
animals. The juvenile unfamiliar rat was constrained within the
cylinder to prevent any type of direct physical contact and to
ensure that all social approaches were initiated by the test rat. The
ratio of juvenile exploration was defined as the time spent
exploring the juvenile rat divided by the time spent exploring the
juvenile rat plus exploration of the object. The time spent sniffing
each cylinder in an active, exploratory behavior toward the
juvenile rat or the object was video-recorded and manually scored
to evaluate the level of preference for the unfamiliar rat compared
with the object. The entire apparatus was cleaned with acetic acid
(0.1%) and completely dried between each test.
Corticosterone Analysis
The concentration of plasma corticosterone was measured
twice. ‘‘Pre-behavioral corticosterone’’ values were obtained
8 weeks after SE and prior to the start of the behavioral testing,
thus indicating the basal plasma corticosterone of chronic epileptic
rats before any stress-inducing behavioral manipulations [23]. The
second ‘‘post-behavioral corticosterone’’ sample was obtained one
week after completion of all the behavioral experiments. The
reasoning behind this measurement was to compare the levels of
circulating corticosterone between epileptic and control animals
and to examine possible effects of mild stress (behavioral
manipulations such as handling and behavioral tests) on the
animals. Blood samples were taken by nicking the tail during the
light phase (9:00 to 13:00 h), when corticosterone levels have been
shown to be low and stable [24]. Blood samples (100 ml) were
collected in heparinized test tubes (Sarsted, Nu ¨mbrecht, Ger-
many), and the blood was separated by centrifugation for 20 min
at 1500 rpm. The plasma was collected and stored at 280uC until
the corticosterone levels were assayed by ELISA.
Statistics
The results are reported as the mean 6 SEM unless otherwise
indicated. Data analysis was performed using the statistical
software SPSS 18.0 for Windows. Mean comparisons were
performed with factorial ANOVA, with strain (Wistar and
Sprague-Dawley) and treatment (Control, LIP and KA) as the
factors. Tukey’s HSD post hoc paired comparison tests were
performed when appropriate. The differences between corticoste-
rone samples were analyzed using repeated-measures ANOVA
with treatment groups (Control, LIP and KA) including values for
both rat strains; for this analysis, groups were pooled because there
was no difference between strain and sample time point (pre- or
post-behavioral corticosterone) as repeated measures. In addition,
we performed Pearson correlation analyses to evaluate possible
associations between the emotional behavioral parameters and
corticosterone measurements. Results were considered significant
at P,0.05.
Results
We have recently shown that different SE models produce
different types of brain lesions and different behavioral outcomes
in spatial memory tasks and in unconditioned spontaneous tests for
measuring anxiety-like behaviors [11]. More precisely, we
examined epileptic rats after either kainic acid or lithium-
pilocarpine treatment to induce SE. In this study, using these
two SE models, we evaluated whether the emotional behavior of
animals was also differentially affected in tests for anxiety- and
depressive-like symptoms.
Depressive–like Behaviors
Depressive symptoms were assessed through the saccharin
reward test, which evaluated symptoms of anhedonia (i.e.,
hyposensitivity to pleasure), and the social interaction test, which
compares the willingness to preferentially explore a conspecific rat
versus an inanimate object.
A factorial ANOVA on the saccharin consumption in the
anhedonia test (Fig. 1A) indicated a lack of effect of strain [F(1,
32)=0.93, n.s.] or strain x treatment interaction [F(2, 32)=0.91,
n.s.] but a significant effect of the treatment factor [F(2, 32)=7.43,
P,0.01]. Further paired factorial ANOVAs including two
treatment groups revealed that the treatment effect was mainly
due to a significantly increased saccharin intake in the LIP-treated
rats compared with the KA-treated rats [F(1, 22)=19.78, P,0.01]
and controls [F(1, 18)=5.03, P,0.05]. No differences were
observed between KA-treated and control rats [F(1, 24)=0.75,
n.s.]. When saccharin preference was evaluated (Fig. 1B), a
factorial ANOVA indicated a lack of effect of strain [F(1,
32)=3.04, n.s.], treatment [F(2, 32)=2.57, n.s.] or strain x
treatment interaction [F(2, 32)=0.4, n.s.]. Differences in body
weight cannot explain these results because all groups had similar
weights at the beginning of behavioral testing (Control W:
430.19616.58 mg, Control SD: 423.56612.59 mg, LIP-W:
460.33627.30 mg, LIP-SD: 420.5667.21 mg, KA-W:
462.50614.28 mg, KA-SD: 430.57610.51 mg, F(2, 49)=0.56,
n.s.). Moreover, LIP-treated rats did not drink more water than
the other groups (data not shown). Overall, these results suggest
increased motivation in the LIP-treated animals, irrespective of the
strain, to consume more saccharin than the other groups.
Sociability was subsequently assessed using a social interaction
test. A factorial ANOVA on the ratio of juvenile vs. object
exploration indicated a similar lack of effect of strain [F(1,
44)=1.16, n.s.] or strain x treatment interaction [F(2, 44)=0.02,
n.s.], but a significant effect of the treatment factor
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ANOVAs including the two treatment groups revealed that this
effect was due to both SE-treated groups showing a significantly
lower exploration ratio than the controls [LIP: F(1, 27)=37.82,
P,0.0001; KA: F(1, 30)=5.88, P,0.05]; additionally, the low
exploration ratio of LIP-treated animals was significantly different
from that of KA-treated rats [F(1, 27)=20.01, P,0.0001]. These
treatment differences in exploration ratio were observed despite a
lack of treatment effect in total locomotor behavior
[F(2, 44)=1.36, n.s.](Fig. 2B). Locomotion data, however, depict-
ed an effect of strain [F(1, 44)=5.33, P,0.05], reflecting a mild
increase in distance moved by Wistar SE-rats. No strain x
treatment interaction was found for locomotor behavior in this test
[F(2, 44)=1.73, n.s.]. Overall, these results indicate reduced
motivation for social contact in both SE models irrespective of
the strain, with LIP-treated animals being particularly affected.
Anxiety-like Behaviors
Anxiety-like behaviors were assessed in the open field by
evaluating the time spent in the central zone and total distance
traveled. A factorial ANOVA on the percentage of time spent in
the central zone (Fig. 3A) indicated a significant effect of the
treatment [F(2, 40)=70.39, P,0.0001] and the strain x treatment
interaction [F(2, 40)=10.57, P,0.0001], but a lack of effect of
strain [F(1, 40)=2.49, n.s.]. The treatment effect was due to the
increased time spent in the central zone of the arena by both
treated groups compared to controls [LIP: F(1, 26)=115.57,
P,0.0001; KA: F(1, 28)=47.85, P,0.0001] and to the higher
time spent in this zone by the LIP-treated animals versus KA-
treated rats [F(1, 26)=39.68, P,0.0001]. Post hoc analyses
following the interaction of the 263 factorial ANOVA further
revealed that the percentage of time spent in the central area was
significantly higher for LIP-treated rats than for controls in both
Wistar (P,0.0001) and Sprague-Dawley strains (P,0.0001). The
same pattern was found in KA-treated animals when compared
with their control group (Wistar: P,0.05; Sprague-Dawley:
P,0.01). Furthermore, a factorial ANOVA performed on the
distance traveled in the arena (Fig. 3B) failed to indicate an effect
of strain [F(1, 40)=0.15, n.s.] or a strain x treatment interaction
[F(2, 40)=3.33, n.s.] but revealed a tendency towards statistical
significance for the treatment factor [F(2, 40)=3. 51, P=0.09.],
mainly due to higher values in the rats belonging to the SE models.
Corticosterone Levels
The analysis of plasma corticosterone concentrations showed a
main effect for the time at which samples were taken (pre- and
post-behavioral) as well as an interaction between sampling and
group [F(1, 26)=8.43, P,0.01 and F(2, 26)=7.41, P,0.01,
respectively] but did not show a main effect for the group [F(2,
26)=1.01, P=0.38]. Subsequent Bonferroni-corrected pair-wise
comparisons between each pair of samples for each group
Figure 1. Anhedonia test. (A) Saccharin consumption and (B)
saccharin preference was assessed in all groups simultaneously. The
data for saccharin consumption per 100 g body weight (A) showed
increased saccharin intake in LIP-treated rats compared with controls
and KA-treated animals, regardless of the strain. The data for saccharin
preference (B) indicated no differences between groups. The results are
presented as the mean 6 SEM. # P,0.05; ** P,0.01. Abbreviations: W:
Wistar; SD: Sprague-Dawley; LIP: lithium-pilocarpine; KA: kainic acid.
doi:10.1371/journal.pone.0038959.g001
Figure 2. Social interaction test. (A) The juvenile exploration ratio
represents time spent exploring the juvenile rat over the total time
spent exploring the juvenile rat and the object, evaluated during the
10 min session of the test. Both SE models regardless of the strain, but
especially LIP-treated animals, showed decreased preference for
exploration of the juvenile conspecific. (B) Total distance traveled in
the social interaction test. The results are presented as the mean 6
SEM. * P,0.05; *** P,.0001; +++ P,.0001. Abbreviations: W: Wistar; SD:
Sprague-Dawley; LIP: lithium-pilocarpine; KA: kainic acid.
doi:10.1371/journal.pone.0038959.g002
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behavioral corticosterone concentration (t=-4.60, df=7, P,0.01)
than their initial corticosterone concentration (Fig. 4). Interesting-
ly, KA-treated animals did not show differences between the two
samples (t=0.38, df=13, P=0.71), similar to control rats (t=-
0.66, df=7, P=0.53).
Correlations between Corticosterone Levels and
Emotional Behavior
Altogether, our results showed differences between the LIP and
KA SE models regarding the affective symptoms and the
functional state of the HPA axis. To establish a connection
between alterations in the HPA axis and emotional behavior, we
carried out correlation analyses between the main measures of
affective behavior in the behavioral tests performed and between
those measures and corticosterone levels.
First, we evaluated whether there was correlation between
anxiety- and depression-like behaviors. We found a negative
correlation (r=-0.565, P,0.01) between the anxiety-like mea-
surements from the open-field (OF) and behaviors in the social
interaction test (Fig. 5A). In addition, we found a positive
correlation between the time spent in the central area of the OF
and the post-behavioral corticosterone level (r=0.508, P,0.01;
Fig. 5B), indicating that the greater the increase in the
corticosterone levels (i.e., hyperactivity of the HPA axis), the
lower the anxiety (i.e., the more time spent in the central area in
the OF). Again, we found a negative correlation (r=-0.452,
P,0.05; Fig. 5C) between post-behavioral corticosterone concen-
tration and performance in the social interaction test, suggesting
that the functional activation of the HPA axis is negatively related
to the motivation for social interaction.
Discussion
In this study, we investigated the effects of two SE models of
TLE (LIP and KA) in two rat strains (Wistar and Sprague-Dawley)
using tests for anxiety- and depression-like behaviors as well as
measurements of plasma corticosterone responses. Our results
showed two main findings. First, there are emotional differences
between LIP- and KA-treated models. LIP-treated animals,
irrespective of strain, exhibited alterations in anxiety and
depression-like behaviors. However, KA-treated rats presented
significantly less alteration than LIP-treated animals, and impor-
tantly, displaying only mild changes in social motivation and
anxiety-like behaviors. Furthermore, no differences were observed
between KA-treated animals and the control group in either
anhedonic behavior or basal corticosterone levels. Second, LIP-,
but not KA-, treated animals showed an increase in plasma
corticosterone levels in post-behavioral measurements, indicating a
hyperactivity of the HPA axis in this model of TLE.
Although anhedonia is considered a cardinal symptom of
depression [25], we found no change in KA-treated rats and
increased saccharin consumption in LIP-treated animals, irrespec-
tive of the strain. Despite clear epidemiological links between
depression and epilepsy, there is limited experimental evidence
from animal research to support a shared pathology. Reported
findings using tests for anhedonia are conflicting, indicating no
changes [26,27], loss of taste preference [28] or even changes
depending of the circadian rhythms [29]. Notably, in our study,
the increase in saccharin consumption in LIP-treated rats was not
associated with changes in water consumption or with increased
locomotion, further suggesting that the effect was not due to
changes in physiological processes that might interfere with
ingestion or alter motor behavior. Previous studies also dismiss
the notion of spontaneous seizure activity as a determining factor
in depression-like behaviors, as no correlation between depression-
Figure 3. Open field test. (A) Exploration of the central zone was
measured as an index of anxiety-like behavior. LIP- and KA-treated rats
from both strains showed increased exploration of the central zone. (B)
Total distance traveled. The results are presented as the mean 6 SEM. *
P,0.05, ** P,0.01, and *** P,0.0001 vs. their respective control
groups. Abbreviations: W: Wistar; SD: Sprague-Dawley; LIP: lithium-
pilocarpine; KA: kainic acid.
doi:10.1371/journal.pone.0038959.g003
Figure 4. Plasma corticosterone levels assessed before (pre-
behavioral phase) and after (post-behavioral phase) the
behavioral tests. The results are presented as the mean 6 SEM. **
P,0.01 vs. the corresponding pre-behavioral data from the same
group. For this analysis, strains were pooled. Abbreviations: LIP: lithium-
pilocarpine; KA: kainic acid.
doi:10.1371/journal.pone.0038959.g004
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frequency was previously reported [28,30].
Our data indicate a reduction in the motivation to explore a
juvenile conspecific in both TLE models. This impairment is
particularly pronounced in LIP-treated rats, while KA-treated rats
show only a mild reduction in their social preference. The different
exploratory behavior observed cannot be explained by altered
locomotor behavior in the test. Because reduced social exploration
in rodents is interpreted as a depressive-like phenotype [31], these
data suggest that SE models lead to behavioral alterations that are
congruent with depression-like symptoms. Moreover, differences
in performance observed between LIP- and KA-treated rats
suggest that differences in the extent of brain lesions [11] or in the
anatomical organization of the temporal lobe caused by each of
these two TLE models may underlie the differences in social
behaviors [32].
We found clear differences in the time spent in the central zone
of the open field, indicative of differences in anxiety-like behaviors
between the SE models rat strains. Although KA-treated rats
showed a mild reduction in anxiety levels, LIP-treated rats
expressed very low levels of anxiety-like behavior. These data
are in agreement with our previous observations using the elevated
plus maze [11]. Anxiety-like behaviors reported in experimental
models of epilepsy studies are contradictory, with some studies
reporting increased anxiety levels [5], and others that accord with
our results by indicating decreased anxiety levels [6,33]. Previously
[6], it has been hypothesized that these types of behavioral
alterations might reflect disinhibited behavior. Ventral lesions of
the hippocampus can alter unconditioned fear responses to
threatening situations. Our previous study [11], in accordance
with other reports [17], showed that TLE models induce extensive
lesions of the ventral and dorsal hippocampus; particularly in LIP-
treated animals, large lesions are also observed in the amygdala.
Differences in the extent of the amygdala lesion might be
responsible for variations in the assessment of threatening
situations. This hypothesis is in agreement with our previous
findings [11], which indicated that extension of brain damage,
mostly affecting the lateral and basolateral amygdala, was
correlated with another anxiety-related behavior test (the time
spent in the open arms of an elevated plus maze). Consequently,
these observations suggest that differences in the emotional
reactivity might be more related with the underlying brain lesions
than with the epileptic condition per se.
We also observed subtle strain differences in the magnitude of
the anxiety effects, in line with previous data indicating that the
strain factor interferes with the expression of epileptic phenotypes
and behavioral performance [29,34,35]. Genetic heterogeneity
among various rodent strains has been linked with their different
response to epileptogenic inducers [36–38]. Several studies have
shown evidence indicating that genetic heterogeneity may account
for the observed discrepancies in measures of seizure-induced
neuronal damage and behavioral differences [34,39,40].
Our results are in agreement with previous evidence showing
hyperactivity of the stress hormone corticosterone in animal
models of epilepsy, as evaluated during seizures or either post-ictal
or interictal activity [41–44]. Interestingly, Mazarati et al. [44]
showed that experimental TLE (accompanied by interictal HPA
dysregulation) is correlated with increased depressive behaviors in
the forced swimming test. It should also be noted that most of the
behavioral tests typically used to evaluate depressive symptoms are
also potentially stressful for animals (e.g., forced swimming test,
social interaction test) and might produce a stress-induced hyper-
reactivity of the HPA axis, including an increase in glucocorticoids
[45]. Given that only LIP-treated rats presented alterations in
corticosterone levels, it is tempting to suggest that their behavior in
anhedonic and sociability tests might be affected by dysregulation
of HPA activity and their response to stress.
In humans [46,47] and animals [44], HPA hyperactivity was
shown to be independent of seizure frequency, suggesting that
chronic HPA dysfunction is associated with the epileptic condition.
In a previous report, we did not find apparent differences in the
seizure severity between SE models and strains [11]. Instead, we
propose that alterations in the HPA axis are not part of the
epileptic condition but, rather, are associated with the extension of
the brain lesions induced by SE [11,16,32]. The minor impair-
ment of emotional capabilities in KA- versus LIP-treated animals
suggests that rats submitted to SE do not necessarily develop the
same severity of affective disorders or HPA dysfunction. More-
over, our previous report [11] showed that there are important
differences between models regarding the severity of brain lesions
produced by SE; thus, pilocarpine and kainate models already
exhibit distinct lesional patterns 24 h after SE [16]. In pilocarpine-
injected rats, substantial multifocal damage is produced, affecting
parahippocampal cortical regions, the thalamus, the endopiriform
cortex and the amygdaloid nuclei [14–16]. In contrast, the kainate
SE model induces less acute damage, with brain areas affected at a
lower intensity than in the pilocarpine SE model [16]. There are
important anatomical and functional connections between the
hippocampus, amygdala and the HPA axis [48,49], and a link
between dysregulation of HPA axis and depression and anxiety
disorders is also well known [50]. In agreement with previous data
[51], we found reduced levels of anxiety-like behavior in the open
Figure 5. Statistical correlations (including all animals) between post-behavioral corticosterone levels and behavioral indices
obtained in the social interaction and open field tasks. (A) Correlation between behavioral parameters in the open field and social interaction
test. Symbol code: (N) control Wistar, (#) control Sprague-Dawley, (&) lithium-pilocarpine Wistar, (%) lithium-pilocarpine Sprague-Dawley, (m)
kainate Wistar and (D) kainate Sprague-Dawley. (B) Correlation between the exploration in the inner zone in the open field and the post-behavioral
corticosterone levels. (C) Correlation between the juvenile exploration ratio in the social interaction test and post-behavioral corticosterone level.
doi:10.1371/journal.pone.0038959.g005
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animals with intact amygdala nuclei, further implicating a
functional separation between the TLE condition and anxiety-
like disorders. In addition, our results suggest that this functional
separation can impact depressive symptoms, which are manifested
as a decrease in social motivation exhibited by LIP-treated
animals. In accordance with these data, we argue that epileptic
animals with severe damage to the amygdala and hippocampus
are more likely to exhibit a dysregulation of the HPA axis and
alterations in social interaction tests. In support of this idea, we
found high correlations between the post-behavioral increase in
plasma corticosterone and emotional behaviors.
In conclusion, we suggest that altered emotional behaviors are
not necessarily part of the epileptic condition in experimental
models of TLE; instead, they are likely to reflect a shift in anxiety
levels related to a dysregulation of the HPA axis caused by model-
dependent lesions.
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